Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Bay 11-7821: NF-κB Assay Workflow Guide
2026-09-16
Bay 11-7821, also called BAY 11-7082, provides a practical downstream perturbation point for separating NF-κB-dependent inflammation from lactate-driven macrophage responses. This workflow guide covers dose finding, reporter and protein readouts, exosomal HMGB1 experiments, apoptosis applications, and troubleshooting of solubility and cytotoxicity artifacts.
-
EZ Cap™ Mouse CD80 mRNA (m1Ψ, HA tag): Assay Design
2026-09-16
EZ Cap™ Mouse CD80 mRNA (m1Ψ, HA tag) enables a controlled way to study mouse CD80-mediated T-cell co-stimulation. This guide translates published tumor-vaccine findings into practical assay design, controls, readouts, and interpretation strategies.
-
Necrostatin-1 and RIP1: A Translational Lens
2026-09-15
A mechanism-first guide to using Necrostatin-1 as a RIP1 kinase inhibitor in necroptosis assays and translational injury models, with a strategic framework connecting microbial virulence, Crohn’s disease biology, and host-cell death without overstating the evidence.
-
CCCP as a Functional Stress Test for Mitochondria
2026-09-15
CCCP, or carbonyl cyanide m-chlorophenyl hydrazine, is more than an oxidative phosphorylation uncoupler. This article explains how controlled mitochondrial proton gradient disruption can strengthen live-cell morphology assays and improve interpretation of urine-derived stem cell biomarker research.
-
HLTP1 and JNK Signaling in Liver Ischemia-Reperfusion
2026-09-14
This study identifies human liver transplantation peptide 1 (HLTP1) through peptidomic analysis of clinical liver-transplant samples and reports protection against hepatic ischemia-reperfusion injury (HIRI). Mouse and AML12-cell experiments connect the benefit to suppression of Jun N-terminal kinase (JNK) phosphorylation and reduced hepatocyte apoptosis, providing a mechanistic basis for further peptide development.
-
Octyl-α-ketoglutarate for Reliable Cell Assays
2026-09-14
Learn how Octyl-α-ketoglutarate, SKU C4321, can help distinguish metabolic changes from true loss of cell viability in HIF and IDH-focused experiments. This scenario-based guide covers assay design, solvent controls, protocol handling, interpretation, and practical product selection.
-
Phalloidin (B7678): F-Actin Workflow Guide
2026-09-13
Phalloidin (B7678) is a cyclic heptapeptide toxin that binds filamentous actin and supports actin filament stabilization for microscopy and cell-free assays. It is suited to fixed or permeabilized samples, but not to live-cell imaging or experiments requiring reversible actin dynamics.
-
Tailored CAR Macrophages for Peritoneal Metastasis
2026-09-12
Gu and colleagues developed a macrophage-targeted mRNA lipid nanoparticle platform for programming CAR macrophages directly in the peritoneal cavity. Their comparison of 36 CAR designs identified a CD3ζ–TLR4 intracellular configuration that promoted adaptive immune activation, remodeled the tumor microenvironment, and improved responses to PD-1/L1 blockade.
-
Partial BACE Inhibition and Synaptic Transmission
2026-09-11
Satir et al. show that moderate β-secretase inhibition can reduce amyloid-β secretion without measurably impairing synaptic transmission in cultured rat cortical neurons. The study distinguishes a potentially useful exposure range from stronger BACE inhibition, which reduced both amyloid-β production and neuronal communication.
-
Small Molecules Improve Pancreatic Ductal Organoids
2026-09-11
Liao and colleagues developed a small-molecule culture strategy that improves the initiation and expansion of pancreatic ductal organoids while retaining heterogeneous ductal and acinar populations. The approach offers a more stable exocrine model for pancreatic disease biology, including future drug-screening and pancreatic ductal adenocarcinoma studies.
-
Bestatin Dissects Jasmonate Signaling in Arabidopsis
2026-09-10
The reference study established Bestatin as a chemical-genetic probe for jasmonate signaling rather than merely as an aminopeptidase inhibitor. By combining gene-expression analysis, genetic perturbation, developmental phenotyping, and a bestatin-resistant mutant screen, the authors identified distinct Arabidopsis response classes and candidate regulatory loci.
-
Irinotecan: From Top1 Damage to Assay Design
2026-09-10
Irinotecan (CPT-11) is more than a cytotoxic reagent: it is a controllable system for studying topoisomerase I damage, active-metabolite exposure, and apoptosis. This article connects colorectal cancer assays with lessons from topotecan research while emphasizing experimental interpretation, model selection, and translational limits.
-
Bestatin (Ubenimex): Aminopeptidase Research Guide
2026-09-09
Bestatin, also called Ubenimex, is a natural-product inhibitor used to study aminopeptidase B, leucine aminopeptidase, and related zinc aminopeptidases. Its reported nanomolar-to-micromolar potency profile supports aminopeptidase activity measurement, multidrug resistance research, and mechanistic cancer research, but assay conditions and target identity must be controlled.
-
Pomalidomide (CC-4047) Research Workflows
2026-09-09
Build reproducible multiple myeloma assays with Pomalidomide (CC-4047), from genotype-aware cell-line screening to cytokine and erythroid readouts. This guide combines evidence-linked product parameters with practical dosing, model-selection, and troubleshooting strategies for hematological malignancy research.
-
Patient-Derived Gastric Cancer Assembloids Explained
2026-09-08
The reference study develops a patient-derived gastric cancer assembloid that combines matched tumor organoids with stromal cell subpopulations from the same tumor. Its findings show that stromal composition alters gene expression and drug sensitivity, providing a more physiologically relevant framework for studying tumor–stroma interactions and personalized treatment responses.